Ovarian Cancer Stage IV: Distant metastases (hepatic parenchyma, lung, pleura, brain, etc.) or positive pleural effusion cytology
Reviewed by Oncology Team, HealOnco | Last updated: 2026-04
What Stage IV: Distant metastases (hepatic parenchyma, lung, pleura, brain, etc.) or positive pleural effusion cytology Means
IVA (positive pleural cytology); IVB (liver, lung, brain, or other extraabdominal metastases). About 10-15% at diagnosis in India; 20-25% globally.
Treatment Approach for Stage IV: Distant metastases (hepatic parenchyma, lung, pleura, brain, etc.) or positive pleural effusion cytology
Palliative chemotherapy (carboplatin + paclitaxel + bevacizumab), targeted therapy based on molecular profile, and supportive care. Clinical trials increasingly offer immunotherapy combinations. Goals shift toward quality of life and symptom control; median overall survival 2-3 years with treatment.
Survival Rates and Prognosis
The 5-year survival rate for ovarian cancer at Stage IV: Distant metastases (hepatic parenchyma, lung, pleura, brain, etc.) or positive pleural effusion cytology is approximately 10-20% 5-year survival with multimodal therapy. Survival rates are statistical averages drawn from large patient populations and may not reflect your individual outcome. Factors that influence your specific prognosis include your age, overall health, tumour biology, and how well the cancer responds to treatment.
Important: These numbers are drawn from historical data. Newer treatments available today may improve outcomes beyond what published statistics show. Discuss your individual prognosis with your oncologist.
How Other Stages Compare
| Stage | 5-Year Survival | Treatment |
|---|---|---|
| Stage I: Tumor confined to ovaries | 90-95% 5-year survival | Surgery (unilateral salpingo-oophorectomy or total abdominal hysterectomy +… |
| Stage II: Tumor involves one or both ovaries with extension to pelvis | 70-80% 5-year survival | Optimal surgery (total hysterectomy, bilateral salpingo-oophorectomy,… |
| Stage III: Tumor involves one or both ovaries with peritoneal spread outside pelvis or positive retroperitoneal/inguinal lymph nodes | 40-50% 5-year survival with optimal treatment | Neoadjuvant chemotherapy (3 cycles) followed by debulking surgery, then… |
Ovarian Cancer Treatment in Top Cities
Diagnosed with Stage IV: Distant metastases (hepatic parenchyma, lung, pleura, brain, etc.) or positive pleural effusion cytology Ovarian Cancer?
Our specialists can review your reports and create a personalised treatment plan.
Get a Free Consultation